Results 161 to 170 of about 2,255,889 (297)

Characterization of a P-glycoprotein drug transporter from Toxocara canis with a novel pharmacological profile. [PDF]

open access: yesInt J Parasitol Drugs Drug Resist, 2021
Jesudoss Chelladurai JRJ   +2 more
europepmc   +1 more source

A Holistic Platform Approach for Developing Robust Pulmonary mRNA Delivery: Integrating Novel Phenolic Acid‐Derived Ionizable Lipids and Device Engineering

open access: yesAdvanced Functional Materials, EarlyView.
An integrated pulmonary mRNA delivery platform combining novel biodegradable syringic acid‐derived ionizable lipids, design‐of‐experiments formulation optimization, and vibrating‐mesh nebulizer engineering enabled stable aerosolization and efficient lung delivery.
Neha Kaushal   +21 more
wiley   +1 more source

ABC Transporter Blockers and Reversal of Drug Resistance in Microorganisms.

open access: yes, 2012
One of the major causes of drug resistance and chemotherapeutic failure in both cancer and anti-infective therapies is the decrease of effective drug concentrations at their target place, due to the increased action of ATP-binding cassette (ABC ...
Ponte-Sucre, Alicia   +2 more
core  

Influence of inflammation on drug transporter expression in human airway epithelia: Implications for inhaled drug pharmacokinetics. [PDF]

open access: yesDrug Metab Dispos
Esther CR   +13 more
europepmc   +1 more source

VARIDT 1.0: variability of drug transporter database. [PDF]

open access: yesNucleic Acids Res, 2020
Yin J   +14 more
europepmc   +2 more sources

ZIKV Disrupts Placental Ultrastructure and Drug Transporter Expression in Mice. [PDF]

open access: yesFront Immunol, 2021
Andrade CBV   +10 more
europepmc   +1 more source

An Epigenetic Fate Converter Based on Nuclei‐Targeting Lipid Nanoparticles Drives Neuronal Programming of Stem Cells for Spinal Cord Repair

open access: yesAdvanced Functional Materials, EarlyView.
Schematic illustration of LNP‐MPG nuclei‐targeting delivery of HMW‐FGF2 promoting histone acetylation to regulate the fate of DPSCs and treat spinal cord injury. LNPs components include pHMW‐FGF2 plasmid, DSPC, Dlin‐MC3‐DMA, cholesterol, and PEG2000, and are modified with MPG to form HMW‐FGF2@LNP‐MPG (HLM). HLM nuclei‐targets DPSCs to deliver HMW‐FGF2,
Heng Zhou   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy